Serum nitrite sensitively reflects endothelial NO formation in human forearm vasculature: Evidence for biochemical assessment of the endothelial L-arginine-NO pathway

Cardiovascular Research

Volumn 41, Issue 3, 1999, Pages 765-772

  Kelm, Malte ^a   Preik Steinhoff, Hagen ^a   Preik, Michael ^a   Strauer, Bodo E ^a  

^a Div Cardiol Pulmon Dis A   (Germany)

Author keywords

Acetylcholine; Endothelium derived factors; L Arginine; Nitrite oxide

Indexed keywords

ACETYLCHOLINE; ARGININE; N(G) METHYLARGININE; NITRATE; NITRIC OXIDE; NITRITE; PAPAVERINE;

ADULT; ARM BLOOD FLOW; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL; CONTROLLED STUDY; FEMALE; FOREARM; HUMAN; MALE; NORMAL HUMAN; PLETHYSMOGRAPHY; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ACETYLCHOLINE; ADULT; ANALYSIS OF VARIANCE; ARGININE; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; ENDOTHELIUM, VASCULAR; FEMALE; FOREARM; HUMANS; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITES; OMEGA-N-METHYLARGININE; PAPAVERINE; REGIONAL BLOOD FLOW; REGRESSION ANALYSIS; VASODILATOR AGENTS;

EID: 0032993339     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00259-4     Document Type: Article

References (51)

1. Moncada S., Higgs E.A. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 9:1995;1319-1330.
2. Celermajer D.S. Endothelial dysfunction: Does it matter? Is it reversible? J Am Coll Cardiol. 30:1997;325-333.
3. Vallance P., Collier J. Biology and clinical relevance of nitric oxide. Br Med J. 309:1994;453-457.
4. Wennmalm A. Endothelial nitric oxide and cardiovascular disease. J Intern Med. 235:1994;317-327.
5. Busse R., Fleming I. Regulation and functional consequences of endothelial nitric oxide formation. Ann Med. 27:1995;331-340.
6. Kelm M., Feelisch M., Spahr R. Quantitative and kinetic characterization of nitric oxide and EDRF release from cultured endothelial cells. Biochem Biophys Res Commun. 154:1988;236-244.
7. Feelisch M. The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J Cardiovasc Pharmacol. 17:1991;S25-S33.
8. Kelm M, Feelisch M, Grube R, Motz W, Strauer BE, Metabolism of endothelium-derived nitric oxide in human blood, in Moncada S, Marletta MA, Hibbs Jr JB, Higgs EA, editors. The biology of nitric oxide. 1. Physiological and clinical aspects. London, Colchester: Portland Press, 1992:319-322.
9. Wennmalm A., Benthin G., Edlund A.et al. Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ Res. 73:1993;1121-1127.
10. Kelm M, Yoshida K. Metabolic fate of nitric oxide and related N-oxides. In: Feelisch M, Stamler J, editors. Methods in nitric oxide research. Chichester: John Wiley and Sons, 1996:47-58.
11. Preik-Steinhoff H., Kelm M. Determination of nitrite in human blood by combination of a specific sample preparation with high performance anion-exchange chromatography and electrochemical determination. J Chromatogr B. 685:1996;348-352.
12. Kelm M., Preik M., Hafner D., Strauer B.E. Evidence for a multifactorial process involved in the impaired flow response to nitric oxide in hypertensive patients with endothelial dysfunction. Hypertension. 27:1996;346-353.
13. Preik M., Kelm M., Feelisch M., Strauer B.E. Impaired effectiveness of nitric oxide donors in resistance arteries of patients with arterial hypertension. J Hypertens. 14:1996;903-908.
14. Feigl E.O. Coronary physiology. Physiol Rev. 63:1983;1-205.
15. Kelm M., Schrader J. Control of coronary vascular tone by nitric oxide. Circ Res. 66:1990;1561-1575.
16. Amezcua J.L., Dusting G.J., Palmer R.M.J., Moncada S. Acetylcholine induces vasodilatation in the rabbit isolated heart through the release of nitric oxide, the endogenous nitrovasodilator. Br J Pharmacol. 95:1988;830-834.
17. Malinski T., Taha Z., Grunfeld S.et al. Diffusion of nitric oxide in the aorta wall monitored in situ by porphyrinic microsensors. Biochem Biophys Res Commun. 193:1993;1076-1082.
18. Vallance P., Patton S., Bhagat K.et al. Direct measurement of nitric oxide in human beings. Lancet. 345:1995;153-154.
19. Rees D.D., Palmer R.M.J., Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA. 86:1989;3375-3378.
20. Stamler J.S., Loh E., Roddy M.A., Currie K.E., Creager M.A. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation. 89:1994;2035-2044.
21. Imaizumi T., Hirooka Y., Masaki H.et al. Effects of L-arginine on forearm vessels and responses to acetylcholine. Hypertension. 20:1992;511-517.
22. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:1980;373-376.
23. Harrison D.G. From isolated vessels to the catheterization laboratory. Circulation. 80:1989;703-706.
24. Linder L., Kiowski W., Bühler F.R., Lüscher T.F. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Circulation. 81:1990;1762-1767.
25. Panza J.A., Quyyumi A.A., Brush J.E. Jr., Epstein S.E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 323:1990;22-27.
26. Benjamin N., Calver A., Collier J.et al. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension. 25:1995;918-923.
27. Gödecke A., Decking U.K.M., Ding Z.et al. Coronary hemodynamics in endothelial NO synthase knockout mice. Circ Res. 82:1998;186-194.
28. Bauersachs J., Popp R., Fleming I., Busse R. Nitric oxide and endothelium-derived hyperpolarizing factor: formation and interactions. Prostaglandins Leukotrienes Essent Fatty Acids. 57:1997;439-446.
29. Mombouli J., Vanhoutte P.M. Endothelium-derived hyperpolarizing factor(s): updating the unknown. Trends Pharmacol Sci. 18:1997;252-256.
30. Rees D.D., Palmer R.M.J., Schulz R., Hodson H.F., Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol. 101:1990;746-752.
31. Forte P., Copland M., Smith L.M.et al. Basal nitric oxide synthesis in essential hypertension. Lancet. 349:1997;837-842.
32. Rhodes P.M., Leone A.M., Francis P.L., Struthers A.D., Moncada S. The L-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biochem Biophys Res Commun. 209:1995;590-596.
33. Schultz D.S., Deen W.M., Karel S.F., Wagner D.A., Tannenbaum S.R. Pharmacokinetics of nitrite in humans: role of gastrointestinal absorption and metabolism. Carcinogenesis. 6:1985;847-852.
34. Kurzer M.S., Calloway D.H. Nitrate and nitrogen balances in men. Am J Clin Nutr. 34:1981;1305-1313.
35. Zeballos G.A., Bernstein R.D., Thompson C.I.et al. Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs. Circulation. 91:1995;2982-2988.
36. Nava E., Wiklund N.P., Salazar F.J. Changes in nitric oxide release in vivo in response to vasoactive substances. Br J Pharmacol. 119:1996;1211-1216.
37. Schmidt H.H.H.W., Hofmann H., Schindler U.et al. No NO from NO synthase. Proc Natl Acad Sci USA. 93:1996;14492-14497.
38. Murphy M.E., Sies H. Reversible conversion of nitroxyl anion to nitric oxide by superoxide dismutase. Proc Natl Acad Sci USA. 88:1991;10860-10864.
39. Stamler J.S., Slivka A. Biological chemistry of thiols in the vasculature and in vascular-related disease. Nutr Rev. 54:1996;1-30.
40. Beckman J.S., Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol (Cell Physiol). 271:1996;C1424-C1437.
41. Wink D., Grisham M.B., Mitchell A.G., Ford P.C. Direct and indirect effects of nitric oxide in chemical reactions relevant to biology. Methods Enzymol. 268:1996;12-31.
42. Stamler J.S., Jaraki O., Osborne J.et al. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA. 89:1992;7674-7677.
43. Stamler J.S., Jia L., Eu J.P.et al. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science. 276:1997;2034-2037.
44. Benjamin N., Vallance P. Plasma nitrite as a marker of nitric oxide production. Lancet. 344:1994;960.
45. Bassenge E, Busse R, Pohl U. Abluminal release and asymmetrical response of the rabbit arterial wall to endothelium-derived relaxing factor. Circ Res 1997;61(Suppl. 2):II-68-II-73.
46. Lancaster J.R. Jr. Simulation of the diffusion and reaction of endogenously produced nitric oxide. Proc Natl Acad Sci USA. 91:1994;8137-8141.
47. Liu J., Hughes T.E., Sessa W.C. Dynamic movement of endothelial nitric oxide synthase between golgi and plasma membrane of living cells. Circulation. 96(suppl 8):1997;I-48.
48. Liu J., Garcia-Cardena G., Sessa W.C. Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization. Biochemistry. 35:1996;13277-13281.
49. McDonald K.K., Zharikov S., Block E.R., Kilberg M.S. A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the 'arginine paradox'. J Biol Chem. 272:1997;31213-31216.
50. Addicks K., Bloch W., Feelisch M. Nitric oxide modulates sympathetic neurotransmission at the prejunctional level. Microsc Res Tech. 29:1994;161-168.
51. Lüscher T.F., Diederich D., Stebenmann R.et al. Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Engl J Med. 319:1988;462-467.